Submitted by Anonymous (not verified) on 19 December 2025 - 12:30
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 30, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 30, Status: Authorised